The global Spinal Bulbar Muscular Atrophy (SBMA) Treatment Market is witnessing steady expansion as advances in rare disease research, genetic therapies, and neuromuscular disorder management continue to evolve. SBMA, also known as Kennedy’s disease, is a progressive genetic condition that primarily affects motor neurons, leading to muscle weakness, bulbar dysfunction, and reduced quality...